Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

23 Oct 2007 07:01

Cello Group plc23 October 2007 23 October 2007 Cello Group plc Acquisition of 2CV extends research capabilities Cello Group plc ("Cello", AIM: CLL), the market research and consulting grouphas acquired 2CV Limited ("2CV"), a specialist consumer market researchconsultancy. Initial consideration is approximately £5.4 million with furtherperformance related consideration of up to a maximum of £5.5 million. 2CV, which was founded in 1996 by Vincent Nolan, provides market research andconsultancy services to a number of major global brands. It also advises clientson product development, creative marketing communications and strategic mediaplanning. The initial consideration consists of approximately £5.4 million of which £3.5million is payable in cash and loan notes, with the balance satisfied by theissue of 1,330,731 new ordinary shares. In addition, there are furtherperformance related payments over the period to 31 December 2010. These furtherpayments are in a mixture of loan notes and new ordinary shares at Cello'sdiscretion, with a minimum overall loan note consideration of approximately 50%of the further consideration. For the year to 31 May 2007, 2CV had an audited turnover of £5.7 million, grossprofit of £4.0 million and profits before tax of £0.7 million. Net assets as at31 May 2007 were £0.7 million including cash of £0.5 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 26 October2007. Kevin Steeds, Cello Chairman, said: "2CV has an excellent reputation within the marketing industry as athought-leading and innovative consumer insight agency. The 2CV acquisition isconsistent with our strategy of building a substantial international research &consulting group." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Rozi Morris 020 7457 2020 Evolution SecuritiesBobbie Hilliam 020 7071 4347 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of £100 million, operating income ofover £55 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jul 20204:59 pmPRNForm 8.3 - Cello Health Plc
6th Jul 20203:45 pmRNSForm 8.3 - Cello Health plc
6th Jul 20203:13 pmRNSForm 8.3 - CELLO HEALTH PLC
6th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
6th Jul 202012:15 pmRNSForm 8.3 - Cello Health Plc
6th Jul 20207:00 amRNSUpdate on irrevocable undertakings
3rd Jul 20203:20 pmRNSForm 8.3 - Cello Health
3rd Jul 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
3rd Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
3rd Jul 20202:30 pmRNSForm 8.3 - Cello Health PLC
3rd Jul 202011:53 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20209:36 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20207:00 amRNSReplacement - Form 8 (OPD) - Cello Health plc
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20206:26 pmRNSForm 8.3 - Cello Health plc
2nd Jul 20203:20 pmRNSForm 8.3 - Cello Health
2nd Jul 20202:29 pmRNSForm 8.3 - CELLO GROUP PLC
2nd Jul 20201:07 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202012:17 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202010:57 amRNSForm 8.3 - CELLO HEALTH PLC
2nd Jul 202010:26 amGNWForm 8.3 - [Cello Health plc - Opening Declaration] - (HH Ltd)
2nd Jul 202010:25 amRNSForm 8.3 - Cello Health Plc
2nd Jul 20208:53 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20207:00 amRNSUpdate on letters of intent
2nd Jul 20207:00 amRNSForm 8 (OPD) - Cello Health plc
1st Jul 20205:21 pmGNWForm 8.3 - Cello Health plc
1st Jul 20203:31 pmPRNForm 8.3 - Cello Health
1st Jul 20209:05 amRNSForm 8.3 - Cello Health plc
1st Jul 20207:00 amRNSRECOMMENDED CASH OFFER
15th Jun 202010:09 amRNSHolding(s) in Company
11th Jun 20203:48 pmRNSHolding(s) in Company
20th May 20201:05 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement
5th May 20207:00 amRNSIssue of Equity
21st Apr 20207:00 amRNSAnnual Report and Notice of AGM
17th Apr 20209:46 amRNSTotal Voting Rights
14th Apr 20205:18 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:37 amRNSGrant of Options
18th Mar 20207:00 amRNSPreliminary Results
7th Feb 202012:19 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSSettlement with Access Intelligence
22nd Jan 20204:40 pmRNSBlock listing Interim Review
16th Jan 20207:00 amRNSPre-Close Trading Statement
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company
7th Oct 20191:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.